For example, in bladder cancer, Y chromosome loss contributes to tumour immune evasion23 while in colorectal carcinoma, upregulation of KDM5D expression alters cell adhesion, antigen presentation and anti-tumour immunity, accounting for differences between male and female tumours34. Here, KDM5D is linked to urinary bladder carcinoma.